Evidence map›Paper›PMID 39500966›Full record

ArticleScientific reports2024

First documentation of a clinical multidrug-resistant Enterobacter chuandaensis ST2493 isolate co-harboring bla

Ruyan Chen, Chenyu Li, Hao Xu, Ruishan Liu, Haoyu Ge, Jie Qiao, Yi Liu, Xiaojing Liu, Lei Fang, Yanhao Shen and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. First report of a carbapenem-resistantCurrent research in microbial sciences · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ruyan ChenDepartment of Laboratory Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Chenyu LiDepartment of Laboratory Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Hao XuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Ruishan LiuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Haoyu GeDepartments of Microbiology and General Intensive Care Unit of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Jie QiaoDepartment of Laboratory Medicine, the Eight Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China.
Yi LiuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Xiaojing LiuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Lei FangDepartment of Laboratory Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yanhao ShenDepartment of Laboratory Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xiaobing GuoDepartment of Laboratory Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. gxbing928@zzu.edu.cn.

Funding

CAMS Innovation Fund for Medical Sciences 2019-I2M-5-045Fundamental Research Funds for the Central Universities 2022ZFJH003Henan Provincial Science and Technology Research Project 232102310176National Key R&D Program of China 2020YFE0204300National Natural Science Foundation of China 82072314Research Project of Jinan Microecological Biomedicine Shandong Laboratory JNL-2022011BShandong Provincial Laboratory Project SYS202202
6 · The paper itself

Abstract

The increasing prevalence of carbapenem-resistant Enterobacter cloacae complex (CREC) poses great challenges to infection treatment in the clinical setting. In this study, we reported the emergence of carbapenemase in a rare species, Enterobacter chuandaensis, belonging to the Enterobacter cloacae complex (ECC). We elucidated the genetic characteristics of carbapenem-resistant isolate FAHZZU5885, co-harboring bla

Indexed as

Bacterial Proteinsbeta-LactamasesDrug Resistance, Multiple, BacterialEnterobacteriaceae InfectionsMicrobial Sensitivity TestsPlasmidsAnti-Bacterial AgentsCarbapenemsEnterobacterHumansWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase KPC-2beta-lactamase NDM-1beta-LactamasescarbapenemaseCarbapenemsbla KPC−2bla NDM−1CarbapenemaseEnterobacter chuandaensisGenomics

Identifiers

PMID39500966
PMCPMC11538481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.